These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10856565)

  • 1. Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients: 6-year experience at the Sheba Medical Center.
    Lavee J; Bar-Zohar D; Har-Zahav Y; Freimark D; Casif Y; Shinfeld A; Smolinsky AK
    Transplant Proc; 2000 Jun; 32(4):737-9. PubMed ID: 10856565
    [No Abstract]   [Full Text] [Related]  

  • 2. Rabbit antithymocyte globulin induction immunosuppression in heart transplantation.
    Chien NC; Lin FL; Chou NK; Hsu RB; Wang SS; Chu SH; Ko WJ
    Transplant Proc; 2000 Nov; 32(7):2380-2. PubMed ID: 11120209
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-T-cell-antibody prophylaxis in children: success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum.
    Boucek MM; Pietra B; Sondheimer H; Luna M; Shaffer E; Hall P; Campbell D
    Transplant Proc; 1997 Dec; 29(8A):16S-20S. PubMed ID: 9414669
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute cardiac ongoing rejection: comparison between different strategies.
    Forni A; Faggian G; Luciani GB; Lamascese N; Mazzucco A
    Transplant Proc; 2001 May; 33(3):2395-7. PubMed ID: 11377573
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of mycophenolate mofetil in heart transplantation.
    Mathieu P; Carrier M; White M; Pellerin M; Perrault L; Pelletier G; Robitaille D; Pelletier LC
    Can J Surg; 2000 Jun; 43(3):202-6. PubMed ID: 10851414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuncts to triple-drug therapy after cardiac transplantation: a comparison of Nashville rabbit antithymocyte serum to OKT3.
    Aziz S; Kruse AP; Roby PV; Allen MD; Khan K; Fishbein D
    Transplant Proc; 1994 Oct; 26(5):2721-3. PubMed ID: 7940852
    [No Abstract]   [Full Text] [Related]  

  • 7. Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.
    Copeland JG; Icenogle TB; Williams RJ; Rosado LJ; Butman SM; Vasu MA; Sethi GK; McDonald AN; Klees E; Rhenman MJ
    J Thorac Cardiovasc Surg; 1990 May; 99(5):852-60. PubMed ID: 2329823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of acute rejection in kidney grafts treated with initial quadruple therapy: a retrospective analysis comparing two ATGs.
    Civati G; Minetti E; Busnach G; Perego A; Brando B; Broggi ML; Sansalone V; Forti D
    Transplant Proc; 1998 Jun; 30(4):1343-5. PubMed ID: 9636546
    [No Abstract]   [Full Text] [Related]  

  • 9. Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation.
    Aziz TM; Sheldon S; el-Gamel A; Krysiak P; Campbell C; Rahman A; Dyer P; Yonan N; Deiraniya A
    Transplant Proc; 1998 Aug; 30(5):1917-9. PubMed ID: 9723332
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
    Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
    J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients.
    Hanrahan JS; Ibrahim H; Tolman D; Kirchberg D; Salter D; Guerraty A; Mohanty PK
    Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of rejection on late graft function after heart transplantation.
    Livi U; Milano A; Caforio AL; Grassi G; Feltrin G; Boffa GM; D'Agnolo A; Angelini A; Thiene G; Casarotto D
    Transplant Proc; 1994 Oct; 26(5):2727-8. PubMed ID: 7940855
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven-year experience with rabbit antithymocyte globulin after cardiac transplantation at the Montreal Heart Institute.
    Beaufigeau M; Dumesnil D; Carrier M; White M; Pelletier GB
    Transplant Proc; 1997 Nov; 29(7A):10S-12S. PubMed ID: 9366918
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for early mortality, acute rejection, and factors affecting first-year survival after heart transplantation.
    Aziz T; el-Gamel A; Krysiak P; Rahman A; Campbell C; Yonan N; Deiraniya A
    Transplant Proc; 1998 Aug; 30(5):1912-4. PubMed ID: 9723330
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
    Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR
    Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
    Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG
    J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.
    MacDonell RC; Van Buren DH; Richie RE; Johnson HK; Nylander WA; Helderman JH; Ynares CM; Trusler LA; Green WF; Crowe DA
    Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
    Pham SM; Kormos RL; Kawai A; Murali S; Hattler BG; Demetris AJ; Griffith BP
    Transplant Proc; 1996 Apr; 28(2):1002-4. PubMed ID: 8623208
    [No Abstract]   [Full Text] [Related]  

  • 20. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.
    Marcus N; Khaghani A; Burke M; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.